Melinta Therapeutics, Inc., a commercial-stage company focused on the development and commercialization of novel antibiotics, has appointed Christine Ann Miller as President and Chief Executive Officer and member of the board, effective August 3, 2020. In April of this year, Melinta became privately owned by affiliates of healthcare investment firm Deerfield Management Company, L.P. Melinta expects to build upon its existing platform and enhance its antibiotics portfolio with additional produ...